SAI
REGN icon

Savvy Advisors Inc’s Regeneron Pharmaceuticals REGN Stock Holding History

Savvy Advisors Inc’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.36M Buy
2,185
+4
+0.2% +$2.72K 0.03% 431
2026
Q1 		$1.69M Sell
2,181
-21
-1% -$16.1K 0.05% 304
2025
Q4 		$1.7M Buy
2,202
+260
+13% +$177K 0.05% 259
2025
Q3 		$1.09M Buy
1,942
+357
+23% +$202K 0.05% 255
2025
Q2 		$832K Buy
1,585
+379
+31% +$212K 0.06% 249
2025
Q1 		$765K Sell
1,206
-39
-3% -$26.8K 0.08% 207
2024
Q4 		$887K Buy
+1,245
New +$1.04M 0.11% 159

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Savvy Advisors Inc's REGN Position: Q2 2026 in Review

Savvy Advisors Inc increased its Regeneron Pharmaceuticals (REGN) stake by 0.18% in Q2 2026, buying an estimated $2.72K and bringing the position to 2,185 shares worth $1.36M. The position accounts for 0.03% of the portfolio, ranked #431.

Savvy Advisors Inc first reported a position in REGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.7M in Q4 2025. 1,340 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Savvy Advisors Inc held 2,185 shares of Regeneron Pharmaceuticals worth $1.36M as of Q2 2026.
  • Savvy Advisors Inc bought 4 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $2.72K.
  • Regeneron Pharmaceuticals made up 0.03% of Savvy Advisors Inc's portfolio in Q2 2026, its #431 holding.
  • Savvy Advisors Inc first reported a position in Regeneron Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • Savvy Advisors Inc's Regeneron Pharmaceuticals position peaked at $1.7M in Q4 2025.
  • 1,340 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Savvy Advisors Inc's 13F filing for Q2 2026, filed 3 Aug 2026.